Core Viewpoint - Yixin Pharmaceutical Group Co., Ltd. has approved an investment by its wholly-owned subsidiary, Guizhou Hongxiang Yixintang Pharmaceutical Chain Co., Ltd., to acquire land use rights and associated structures for a total investment of RMB 32.8 million [2]. Group 1: Investment Details - The investment involves acquiring land use rights and buildings located at No. 13, Longdongbao Food Industrial Park, Nanning District, Guiyang City, which has a building area of 17,521.25 square meters [2]. - The total area of the land parcel is 26,122.49 square meters, designated for industrial use [2][4]. - The land use rights are granted for a period starting from January 15, 2014, to January 15, 2064 [4]. Group 2: Legal and Administrative Aspects - The land use rights have been officially registered, and the company has obtained the "People's Republic of China Real Estate Property Certificate" for the property [2]. - The rights are classified as state-owned construction land use rights with a transfer nature [2].

一心为民 全心服务 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 一心堂药业集团股份有限公司(以下简称"公司")于2024年12月26日召开第六届董事会第 七次临时会议，审议通过《关于同意全资子公司贵州鸿翔一心堂医药连锁有限公司对外投资取 得土地使用权及其地上附着物的议案》，同意全资子公司贵州鸿翔一心堂医药连锁有限公司（以 下简称"贵州一心堂"）以自有资金人民币3,280万元投资取得贵州方鸿实业有限责任公司位于 贵阳市双龙新区跨越大道南明区龙洞堡食品工业园A区13号地块分割出来的土地使用权及其地 上附着物。具体内容详见公司2024年12月28日在指定信息披露媒体《证券时报》《中国证券报》 《证券日报》和巨潮资讯网（www.cninfo.com.cn）刊登的《关于同意全资子公司贵州鸿翔一心 堂医药连锁有限公司对外投资取得土地使用权及其地上附着物的公告》（公告编号：2024-163 号）。 近日，贵州一心堂已完成土地使用权变更登记事项，并取得坐落于南明区龙洞堡食品工业 园G(13)33号地块的《中华人民共和国不动产权证书》及其地上附着物（建筑物面积17521.2 ...

A股医药商业板块水下拉起，一心堂封板涨停，漱玉平民、健之佳、华人健康、第一医药、益丰药房等 跟涨。 ...

Group 1: Store Transformation and Impact - The selection of existing store locations is based on the target demographics of each region, with a focus on transforming suitable stores for new product lines [2] - The non-pharmaceutical product sales ratio has increased post-transformation, but this does not negatively impact pharmaceutical sales, as the latter remains the core business [3] - Data from sample stores indicate that after transformation, transaction frequency has increased, leading to higher sales and customer traffic [4] Group 2: Product Categories and Profitability - Different product categories have varying profit margins, with both high and low-margin items present in each category [5] - Transformed stores have reported higher profit margins post-renovation, with increased customer traffic and sales driven by innovative products [6] Group 3: Cost and Training Considerations - The transformation of stores does not significantly increase fixed asset or labor costs, as display optimization and collaboration with suppliers help manage expenses [7] - Training for staff on innovative product sales is conducted collaboratively by suppliers and the company's management to ensure employees are well-informed [7]

Group 1: Investor Relations Activity Overview - The investor relations activity was conducted on June 4, 2025, from 14:00 to 15:00 [2] - The event took place at the headquarters of Yixin Tang Pharmaceutical Group Co., Ltd. [2] - A total of 23 investors participated, including representatives from Zhongtai Securities, CITIC Securities, and Morgan Fund [2] Group 2: Participants and Company Representatives - Company representatives included Ms. Guo Chunli (Director), Mr. Liu Jun (Director of Non-Pharmaceutical Business), and Mr. Xie Jianbing (Deputy General Manager of Yunnan Company) [2] - The event was attended by various analysts and investors from different securities firms [2] Group 3: Activity Type and Content - The activity was categorized as an on-site visit [2] - The main content of the investor relations activity was focused on investor communication [2]

一心为民 全心服务 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 一心堂药业集团股份有限公司(以下简称"公司")本次为全资子公司山西鸿翔一心堂药业 有限公司(以下简称"山西一心堂"或"债务人")和云南鸿云医药供应链有限公司(以下简称 "鸿云医药"或"债务人")提供连带责任保证方式的担保，被担保企业山西一心堂和鸿云医药 最近一期的资产负债率超过70%，敬请投资者充分关注担保风险。 一、担保情况概述 公司于 2024 年 11 月 26 日召开第六届董事会第十二次会议，于 2024 年 12 月 13 日召开 2024 年度第三次临时股东大会，审议通过《关于同意子公司向相关银行申请综合授信额度并为其提 供担保的议案》，同意公司担保全资子公司山西一心堂向兴业银行股份有限公司太原分行申请 综合授信 8,000 万元；于 2025 年 4 月 25 日召开第六届董事会第十四次会议，于 2025 年 5 月 21 日召开 2024 年年度股东会，审议通过《关于同意子公司向相关银行申请综合授信额度并为 其提供担保的议案》，同意公司担保全资子公司鸿云医药向银行申 ...

Market Overview - The Shanghai Composite Index fell by 0.18% on May 27, with 13 industries experiencing gains, led by textiles and apparel (up 1.30%) and the pharmaceutical and biotechnology sector (up 0.97) [1] - The net outflow of capital from the two markets was 19.519 billion yuan, with 8 industries seeing net inflows, primarily in the food and beverage sector, which had a net inflow of 1.006 billion yuan [1] Pharmaceutical and Biotechnology Sector - The pharmaceutical and biotechnology sector rose by 0.97%, with a net inflow of 650 million yuan, and out of 476 stocks in this sector, 372 stocks increased in value, while 94 stocks declined [2] - The top three stocks with the highest net inflow were Longshen Rongfa (1.33 billion yuan), Yuheng Pharmaceutical (1.27 billion yuan), and WuXi AppTec (1.21 billion yuan) [2] - The sector also had notable outflows, with the top three stocks experiencing the largest net outflows being Yixin Pharmacy (-845.979 million yuan), Huadong Medicine (-829.898 million yuan), and Heng Rui Medicine (-752.640 million yuan) [4] Capital Flow in Pharmaceutical Sector - The top gainers in the pharmaceutical sector included Longshen Rongfa (up 11.29%), Yuheng Pharmaceutical (up 9.89%), and WuXi AppTec (up 0.86%) [2] - Conversely, the stocks with the largest capital outflows included Yixin Pharmacy (down 5.20%), Huadong Medicine (up 0.38%), and Heng Rui Medicine (up 0.13%) [4]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 根据《公司法》《上市公司股份回购规则》等相关规定，一心堂药业集团股份有限公司（以下简称"公 司"或"本公司"）通过股份回购专用证券账户持有的本公司股份11,475,900股不享有参与权益分派的权 利。本次权益分派以2024年度权益分派方案实施时股权登记日的总股本585,604,125股扣除公司股份回购 专用证券账户股份数11,475,900股后的574,128,225股为基数，向全体股东每10股派发现金红利3元(含 税)，不送红股，不以资本公积金转增股本，本次预计现金分红总额为172,238,467.50元（含税)。 公司2024年年度权益分派方案已获2025年5月21日召开的2024年年度股东会审议通过，现将权益分派事 宜公告如下： 一、股东会审议通过的权益分派方案情况 1、公司2024年年度股东会审议通过的利润分配方案为：公司决定以2024年度权益分派方案实施时股权 登记日的总股本扣除公司回购专用账户股份数（截至公告披露日，公司股份回购专用证券账户 ...

一心为民 全心服务 股票代码：002727 股票简称：一心堂 公告编号：2025-040 号 一心堂药业集团股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 根据《公司法》《上市公司股份回购规则》等相关规定，一心堂药业集团股份有限公司（以 下简称"公司"或"本公司"）通过股份回购专用证券账户持有的本公司股份11,475,900股不 享有参与权益分派的权利。本次权益分派以2024年度权益分派方案实施时股权登记日的总股本 585,604,125股扣除公司股份回购专用证券账户股份数11,475,900股后的574,128,225股为基数， 向全体股东每10股派发现金红利3元(含税)，不送红股，不以资本公积金转增股本，本次预计现 金分红总额为172,238,467.50元（含税)。 公司2024年年度权益分派方案已获2025年5月21日召开的2024年年度股东会审议通过，现将 权益分派事宜公告如下： 一、 股东会审议通过的权益分派方案情况 1、公司 2024 年年度股东会审议通过的利润分配方案为：公司决定以 2 ...

Market Performance - On May 23, major market indices experienced fluctuations and closed lower, with A-shares trading volume reaching 1.18 trillion yuan, and over 1,100 stocks closing higher, including 52 stocks hitting the daily limit [1] - For the week, the Shanghai Composite Index fell by 0.57%, the ChiNext Index dropped by 0.88%, and the STAR Market 50 Index decreased by 1.47% [1] Individual Stock Performance - Over 1,600 stocks rose this week, with 22 stocks gaining over 30%. Notably, six stocks surged over 50%, with the largest increase being 99.96% for Sanofi [1][2] - Other significant gainers included Huibo Yuntong (301316) and Binhai Energy (000695), both of which saw weekly increases exceeding 60% [1][2] Sector Analysis - Among the stocks that rose over 30%, the pharmaceutical and biological sector had six representatives, followed by light industry manufacturing with three stocks [1] Historical Highs - On May 23, 17 stocks reached historical closing highs, with the pharmaceutical and biological, mechanical equipment, and automotive sectors showing a concentration of high performers [3][4] - The average increase for stocks reaching historical highs was 8.20%, with notable gainers including Xintiandi (301277) and Zhongzhou Special Materials (300963) [3] Institutional Activity - On May 23, ten stocks saw net purchases from institutions, with Yixin Tang (002727) leading at a net buy of 102 million yuan [5][6] - Conversely, institutions sold off stocks such as Hongchuang Holdings (002379) and Tianqimo (002510), each experiencing net sales exceeding 50 million yuan [5][6] Northbound Capital Flow - Northbound capital was present in nine stocks on the trading board, with net purchases in three stocks: Xue Ren Shares (002639), Huibo Yuntong, and Jinlongyu (002882) [7] - Yixin Tang faced the highest net sell-off from northbound capital, totaling 68.98 million yuan [7] Company Announcements - Zhongjin Gold (600489) plans to inject four companies, including Inner Mongolia Jintao, into the company to resolve competition issues [8] - Huakang Clean (301235) won a bid for a healthcare project with a contract value of 60.24 million yuan and a duration of 120 days [8] - Weier Shares (603501) intends to issue H-shares and list on the Hong Kong Stock Exchange [9] - Yunchongma (603130) plans to raise no more than 640 million yuan for a project to produce DTY silk and high-performance leather base fabric [9]